Wells Fargo & Company Coh Bar, Inc. Transaction History

Wells Fargo & Company

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.17 - $0.34 $7 - $14	44 Added 9.89%	489 $0
Q1 2022 May 16, 2022	BUY	$0.25 - $0.43 $1 - $2	6 Added 1.37%	445 $0
Q4 2021 Feb 14, 2022	BUY	$0.34 - $1.0 $48 - $144	144 Added 48.81%	439 $0
Q3 2021 Nov 15, 2021	SELL	$0.96 - $1.62 $2,886 - $4,871	-3,007 Reduced 91.07%	295 $0
Q2 2021 Aug 16, 2021	SELL	$1.09 - $1.49 $457,961 - $626,020	-420,148 Reduced 99.22%	3,302 $4,000
Q1 2021 May 13, 2021	BUY	$1.26 - $2.02 $272,598 - $437,022	216,348 Added 104.46%	423,450 $576,000
Q4 2020 Feb 09, 2021	BUY	$0.9 - $1.54 $38,775 - $66,349	43,084 Added 26.27%	207,102 $278,000
Q3 2020 Nov 05, 2020	BUY	$0.87 - $2.08 $130,671 - $312,409	150,197 Added 1086.73%	164,018 $156,000
Q2 2020 Aug 13, 2020	BUY	$1.08 - $4.0 $14,722 - $54,528	13,632 Added 7212.7%	13,821 $21,000
Q1 2020 May 14, 2020	BUY	$1.01 - $2.74 $190 - $517	189 New	189 $0

1.14K

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $1.19M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.